Common Contracts
5 similar null contracts by Nephros Inc, Ziopharm Oncology Inc, Nile Therapeutics, Inc.
NEPHROS, INC. WARRANT TO PURCHASE COMMON STOCKNephros Inc • June 14th, 2016 • Surgical & medical instruments & apparatus • New York
This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Note and Warrant Purchase Agreement, dated June 3, 2016, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”
NEPHROS, INC. WARRANT TO PURCHASE COMMON STOCKNephros Inc • May 18th, 2015 • Surgical & medical instruments & apparatus • New York
This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated May 12, 2015, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”
NILE THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCKNile Therapeutics, Inc. • June 24th, 2011 • Pharmaceutical preparations • New York
This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated June 20, 2011, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”
ZIOPHARM ONCOLOGY, INC. WARRANT TO PURCHASE COMMON STOCKZiopharm Oncology Inc • September 15th, 2009 • Services-specialty outpatient facilities, nec
This Warrant (this “Warrant”) is being issued in connection with a private placement of common stock and warrants to purchase common stock pursuant to Securities Purchase Agreements dated September 9, 2009, by and among the Company and the Purchasers identified therein (the “Purchase Agreements”). This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Placement Agents’ engagement letter dated August 7, 2009, by and between the Company and Rodman and Renshaw, LLC (the “Engagement Letter”). All such warrants are referred to herein, collectively, as the “Warrants.”
ZIOPHARM ONCOLOGY, INC. WARRANT TO PURCHASE COMMON STOCKZiopharm Oncology Inc • September 15th, 2009 • Services-specialty outpatient facilities, nec
